Major molecular response to imatinib in a patient with chronic myeloid leukemia expressing a novel form of e8a2 BCR-ABL transcript

被引:0
作者
A Tchirkov
J-L Couderc
B Périssel
C Goumy
A Regnier
N Uhrhammer
P Verrelle
M Berger
机构
[1] Centre Jean Perrin,
[2] Service de Cytogénétique Médicale,undefined
[3] CHU – Faculté de Médecine,undefined
[4] UMR 384 INSERM,undefined
[5] Service de Médecine Interne,undefined
[6] CH,undefined
[7] Hématologie,undefined
[8] Faculté de Médecine,undefined
来源
Leukemia | 2006年 / 20卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:167 / 168
页数:1
相关论文
共 50 条
[1]   Major molecular response to imatinib in a patient with chronic myeloid leukemia expressing a novel form of e8a2 BCR-ABL transcript [J].
Tchirkov, A ;
Couderc, JL ;
Périssel, B ;
Goumy, C ;
Regnier, A ;
Uhrhammer, N ;
Verrelle, P ;
Berger, M .
LEUKEMIA, 2006, 20 (01) :167-168
[2]   Imatinib Mesylate Resistance in a Chronic Myeloid Leukemia Patient with a Novel e8a2 BCR-ABL Transcript Variant [J].
Qin, Ya Zhen ;
Jiang, Bin ;
Jiang, Qian ;
Zhang, Yan ;
Jiang, Hao ;
Li, Jin Lan ;
Zhu, Hong Hu ;
Li, Ling Di ;
Liu, Yan Rong ;
Chen, Shan Shan ;
Huang, Xiao Jun .
ACTA HAEMATOLOGICA, 2008, 120 (03) :146-149
[3]   Response to Imatinib Treatment in Chronic Myeloid Leukemia According to BCR-ABL Transcript [J].
Acosta Hernandez, Titania del Carmen ;
Best Aguilera, Carlos Roberto ;
Villela Martinez, Luis Mario ;
Guzman Hernandez, Alicia Elizabeth ;
Robles Rodriguez, Arianna ;
Lopez Hernandez, Juan Carlos ;
Gomez Vazquez, Oscar Rodrigo ;
Rivera Mendoza, Laura Adriana ;
Garcia Reyes, Barbara ;
Gutierrez Alatorre, Aldo Fernando Adrian ;
Calderon Valdez, Areli Sarai ;
Visuetti Pimentel, Saribethe Mahely .
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 :S242-S243
[4]   Identification of a rare e8a2 BCR-ABL fusion gene in three novel chronic myeloid leukemia patients treated with imatinib [J].
Cayuela, JM ;
Rousselot, P ;
Nicolini, F ;
Espinouse, D ;
Ollagnier, C ;
Bui-Thi, MH ;
Chabane, K ;
Raffoux, E ;
Callet-Bauchu, E ;
Tigaud, I ;
Magaud, JP ;
Hayette, S .
LEUKEMIA, 2005, 19 (12) :2334-2336
[5]   Identification of a rare e8a2 BCR-ABL fusion gene in three novel chronic myeloid leukemia patients treated with imatinib [J].
J M Cayuela ;
P Rousselot ;
F Nicolini ;
D Espinouse ;
C Ollagnier ;
M H Bui-Thi ;
K Chabane ;
E Raffoux ;
E Callet-Bauchu ;
I Tigaud ;
J P Magaud ;
S Hayette .
Leukemia, 2005, 19 :2334-2336
[7]   Identification of a rare e8a2 BCR-ABL fusion gene in three novel chronic myeloid leukemia patients treated with imatinib. [J].
Cayuela, JM ;
Rousselot, P ;
Nicolini, F ;
Espinouse, D ;
Ollagnier, C ;
Bui-Thi, MH ;
Chabane, K ;
Raffoux, E ;
Tigaud, I ;
Magaud, JP ;
Hayette, S .
BLOOD, 2005, 106 (11) :287B-287B
[8]   Gender and BCR-ABL transcript type are correlated with molecular response to imatinib treatment in patients with chronic myeloid leukemia [J].
Lin, Han-Xin ;
Sjaarda, Jenny ;
Dyck, Jocob ;
Stringer, Randa ;
Hillis, Chris ;
Harvey, Maria ;
Carter, Ronald ;
Ainsworth, Peter ;
Leber, Brian ;
Pare, Guillaume ;
Sadikovic, Bekim .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2016, 96 (04) :360-366
[9]   A novel BCR-ABL transcript (e8a2) with the insertion of an inverted sequence of ABL intron 1b in a patient with Philadelphia-positive chronic myeloid leukaemia [J].
Branford, S ;
Rudzki, Z ;
Hughes, TP .
BRITISH JOURNAL OF HAEMATOLOGY, 2000, 109 (03) :635-637
[10]   A novel BCR-ABL fusion transcript (e18a2) in a child with chronic myeloid leukemia [J].
V H J van der Velden ;
H B Beverloo ;
P G Hoogeveen ;
Ch M Zwaan .
Leukemia, 2007, 21 :833-835